GGrantIndex
Sort

51,593 grants matching hepatitis

The National Drug Abuse Treatment Clinical Trials Network

$562,466
Walter Nmn Ling · University Of California Los Angeles · U10 · FY2012 · DA

Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults

$562,383
Tobias Gerhard · Rutgers, The State Univ Of N.J. · R01 · FY2021 · AG

Genetic determinants of NAFLD severity and progression

$562,372
Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2014 · DK

Contextual risk factors for hepatitis C among young persons who inject drugs

$562,354
Basmattee Boodram · University Of Illinois At Chicago · R01 · FY2019 · DA

Enhanced Anti-HIV-1 Antibody Responses in African American Women Seropositive for

$562,348
Phillip Berman · University Of California Santa Cruz · R01 · FY2017 · DA

Epigenomics of Air Pollution driven Inflammation, Obesity and Insulin Resistance

$562,302
Shyam Biswal · Johns Hopkins University · U01 · FY2017 · ES

Reducing risk of Anthracycline-related heart failure after childhood cancer

$562,287
Saro Armenian · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA

Cell Biology of Metabolic Disorders

$562,196
William Gahl · National Human Genome Research Institute · ZIA · FY2014 · HG

Gut microbiota mediated bile acid alterations in hepatic carcinogenesis

$562,180
Wei Jia · University Of Hawaii At Manoa · U01 · FY2017 · CA

Hepadnavirus Infections and Liver Cancer

$562,151
William Mason · Research Inst Of Fox Chase Can Ctr · R01 · FY2008 · AI

Genetic Analysis of Molecular Interactions in Coronavirus Replication

$562,101
Paul Scott Masters · Wadsworth Center · R01 · FY2015 · AI

Genetic Analysis of Molecular Interactions in Coronavirus Replication

$562,101
Paul Scott Masters · Wadsworth Center · R01 · FY2014 · AI

Genetic Analysis of Molecular Interactions in Coronavirus Replication

$562,101
Paul Scott Masters · Wadsworth Center · R01 · FY2012 · AI

Immunogenetic Mechanisms of Vaccine Response

$562,100
Gregory A. Poland · Mayo Clinic Rochester · R01 · FY2009 · AI

Molecular Imaging of Liver Fibrosis

$561,953
Bryan Christopher Fuchs · Massachusetts General Hospital · R01 · FY2015 · DK

Sterile inflammation and pyroptotic cell death in liver fibrosis

$561,944
Harold M Hoffman · University Of California, San Diego · R01 · FY2023 · DK

Molecular basis of altered drug metabolism during pregnancy

$561,936
Hyunyoung Jeong · University Of Illinois At Chicago · R01 · FY2019 · HD

Molecular Classification of Human and Mouse Hepatocellular Carcinoma

$561,870
Snorri S Thorgeirsson · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism

$561,819
Steffanie A Strathdee · University Of California, San Diego · R01 · FY2021 · DA

Heat shock protein 90 in alcoholic liver disease: targeting macrophage Function

$561,807
Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AA

Metabolic inflexibility is related to elevated muscle anaerobic glycolysis

$561,803
Joseph A Houmard · East Carolina University · R01 · FY2021 · DK

Circular RNAs in Cholestatic Liver Diseases

$561,785
Huiping Rose Zhou · Virginia Commonwealth University · R01 · FY2024 · DK

Circular RNAs in Cholestatic Liver Diseases

$561,785
Huiping Rose Zhou · Virginia Commonwealth University · R01 · FY2025 · DK

Alpha2/delta1- thrombospondin-3 signaling in the central control of metabolic function

$561,761
Maribel Rios · Tufts University Boston · R01 · FY2025 · DK

CBPR on Hepatitis B Intervention for Underserved Korean Americans

$561,701
Grace X Ma · Temple Univ Of The Commonwealth · R24 · FY2012 · MD